Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial

समान संसाधन

• Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
  द्वारा: Wechsler, M, और अन्य
  प्रकाशित: (2017)
• OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
  द्वारा: Wechsler, M, और अन्य
  प्रकाशित: (2017)
• Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
  द्वारा: Benjamin Terrier, और अन्य
  प्रकाशित: (2023-07-01)
• Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
  द्वारा: Ravi Ranjan Pradhan, और अन्य
  प्रकाशित: (2019-01-01)
• Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
  द्वारा: Giuseppe A. Ramirez, और अन्य
  प्रकाशित: (2022-12-01)